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Introduction 
Macrolides, considered one of the safest options among 
antimicrobials, structurally have a lactone ring bonded 
to one or more deoxy sugar molecules. [1] Macrolides 
share a similar spectrum of antimicrobial activity with 
benzylpenicillin making them useful alternatives for 
people with background of penicillin and cephalosporin 
allergy. [2] Allergic responses to macrolides are rare, 
evidenced in 0.4 to 0.3 % patients. [3] Adverse drug 
reactions (ADRs) due to macrolide therapy are         
generally cutaneous, with presentations ranging from 
urticaria/angioedema, rhinoconjunctivitis, anaphylaxis, 
maculopapular rash (MPR), non-immediate urticaria, 
contact dermatitis, fixed drug eruptions, maculopapular 
rash to acute generalized exanthematous pustulosis 
(AGEP). Severe cutaneous presentations involving 
necrolysis are rare. 
Though macrolide hypersensitivity is not so common, 
literature survey lists down only a few reports of mild to 
moderately severe cutaneous ADRs due to this drug 
class, thus challenging the comprehension of underlying 
immune-allergenic pathophysiology. The current case 
series presents a cluster of few cases of skin reactions 
due to macrolide therapy in pediatric population.  
Case 1 
A 12 year old male child presented with widespread 
erythema and hundreds of small, flacid, confluent, non-
follicular pustules, especially on back neck along with 
groins and flexor aspects of legs. Reaction was observed 
after three days of tablet azithromycin 250 mg once 
daily intake, indicated for upper respiratory tract 
infection (URTI). The rash was associated with mild 
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fever, body ache and malaise, with no mucosal 
involvement. All laboratory investigations were within 
normal limits. The case was diagnosed to be 
azithromycin induced AGEP. The offending drug was 
withdrawn and he was treated conservatively with oral 
methyl prednisone 8 mg (one and a half tablets for three 
days), levocetirizine 5mg once daily, topical application 
of calamine lotion. He responded well to the therapy 
and rash subsided within 3 days. 
Case 2 
A 5 year old male child presented with erythematous 
pruritic rash on his back after intake of clarithromycin 
syrup in dose of 125mg/5ml, indicated for sore throat 
along with moderate grade fever. Concomitantly      
paracetamol syrup was also advised. On the third day of 
treatment initiation, rash appeared at his back and    
medial aspect of his thigh. Laboratory investigations 
involving blood and liver parameters were within     
normal range. Clarithromycin was withdrawn and the 
patient was symptomatically managed with 
levocetirizine syrup and emollients. The rash subsided 
within next two days.  
Case 3 
A 12 year old male child presented with widespread 
erythema and numerous small, flaccid, confluent, non-
follicular pustules, covering the back, neck and flexor 
region of legs, evolving two days after being initiated on 
once daily dosing of clarithromycin 250 mg for URTI. 
The rash was accompanied with fever, body ache and 
malaise. The case was diagnosed as clarithromycin 
induced AGEP and the drug was withdrawn. He was  
treated conservatively with oral methyl prednisolone 8 
mg (one and a half tablets for three days), levocetirizine 
5mg OD and calamine lotion and paracetamol 500 mg 
as needed. He responded well to the therapy. The rash 
subsided slowly. 
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Abstract 
Cutaneous adverse reactions are very common adverse effect of post antibiotic therapy. Cutaneous adverse reactions 
include skin lesions in the form of rashes urticaria, maculopapular rashes, erythema multiforme, Stevens Johnson 
syndrome and toxic epidermal necrolysis. However macrolides, generally considered safer in this regard, are 
frequently used to treat both adult and childhood infections, with favorable outcomes. Cutaneous manifestations of 
this class of antibiotic are scarce. The present case series focuses on conglomeration of few cases of cutaneous 
reactions due to macrolide therapy in both children and adult population.  
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Case 4 
A 15 year old female child presented with erythematous 
maculopapular rash on consuming azithromycin 500mg 
once daily orally, indicated for sore throat. Patient 
reported taking azithromycin at a dose of 500mg once 
daily for two days, after which she developed rash on 
her upper arms. The rash examined to be pruritic,     
progressed to involve medial aspect of thighs and legs 
in a couple of days. The patient was afebrile and the 
rash was however not associated with urinary 
abnormalities or mucosal and conjunctival involvement.           
Laboratory investigations conferred mild decreased 
hemoglobin, raised eosinophils while other hemogram 
and liver parameters along with serum urea and 
creatinine within normal limits. Suspected drug was 
dechallenged. The patient was managed with 
hydroxyzine 25 mg once  daily orally along with topical 
application of calamine lotion as emollient to which she 
responded well.  
Causality assessment of all the reactions conferred it to 
be “probable” with WHO UMC causality assessment 
scale, while the severity of all reactions were assessed to 
be moderate (level 3) as per Hartwig Seigel’s Scale. The 
events were reported under Pharmacovigilance          
Programme of India. 
Discussion 
Cutaneous ADRs accounts for 10–30% of all ADRs, 
and are mostly attributed to antibiotics. Reactions can 
vary in severity mostly being mild-to-moderate grade 
though severe reactions are also estimated to occur in 
0.1–2% of cases. [4] Drug allergy to antibiotics may 
present in the form of immediate or delayed 
hypersensitivity reactions. Manifestations of antibiotic 
allergy may be cutaneous, organ-specific, systemic or a 
combination of these. However allergic reactions to 
macrolides    appear to be relatively uncommon with 
limited case     reports of immediate and delayed 
reactions been      reported, in both children and adults, 
on clarithromycin and azithromycin. In some cases 
successful desensitization has also been reported. [5, 6] 
Despite the rampant use, pediatric safety data regarding 
macrolide usage is scarce in pediatric population. 
Examining a cutaneous ADR needs consideration of          
underlying bacterial infection, viral exanthems if any 
along with exclusion of other idiopathic plausible   
causes. So the clinician should negate all possibilities 
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before coming into a diagnostic conclusion. 
Unavailability of available tests in regular set ups to 
diagnose drug rash creates significant challenge. Careful 
history taking and establishing a definite temporality is 
essential to establish a drug-adverse effect relationship. 
However rechallenge of drug for determining the 
relatedness of a suspected drug with the event is often a 
great challenge, as it may pose a potential risk of life 
threatening response in some cases.  
Management involves identifying the putative antibiotic 
though a detailed medication history, along with in-vivo 
and in-vitro allergological investigations as feasible. 
Drug desensitization is considered in few situations 
where benefits outweigh the risks, and no alternative 
antibiotics can be used for various other reasons. [7] 
Management usually involves prompt withdrawal of the 
suspected drug followed by use of topical steroids for 
reduction of inflammatory response along with oral 
antihistamines and emollients for symptomatic relief. 
Systemic immunomodulatory drugs are also used for 
suppression of severe cutaneous/systemic reactions. 
Conclusion 
Antibiotics, one of the greatest and indispensable 
discoveries in medicine, are not devoid of 
complications. Cutaneous reactions, commonly 
experienced as adverse effects of post antibiotic therapy, 
should be cautiously managed with prompt withdrawal 
of the suspected agent. Avoidance of putative antibiotic 
through proper patient education may minimize the 
chance of reactions in future.  
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